NCCN GUIDELINES AND NCCN COMPENDIUM UPDATED
NCCN Flash Update sent July 21, 2014
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium®) for Non-Hodgkin’s Lymphomas. These NCCN Guidelines® are currently available as Version 3.2014.
- Peripheral T-Cell Lymphomas
- For both candidate and non-candidate for transplant, a new second-line therapy “belinostat” was added with a category 2B recommendation. (TCEL-B 1 of 2)
*For your reference, the previous update (Version 2.2014) to the NCCN Guidelines for Non-Hodgkin’s Lymphomas, distributed on March 28, 2014, is available at the following link:
For the complete updated versions of the NCCN Guidelines, the NCCN Compendium®, and the NCCN Chemotherapy Order Templates (NCCN Templates®), please visit NCCN.org.
To access the NCCN Biomarkers Compendium®, please visit NCCN.org/biomarkers.
To view the NCCN Guidelines for Patients®, please visit NCCN.org/patients.
Free NCCN Guidelines apps iPhone, iPad, and Android devices are now available! Visit NCCN.org/apps